Exin Therapeutics
We use AI and high-throughput mouse studies to discover therapeutics that modify neural activity in the brain. The initial focus is on epilepsies associated with autism and Parkinson’s disease with the potential to expand to any neurological disorder underlined by a dysfunction in neural activity. Our R&D is guided by AI models trained on high-density multimodal mouse data generated in-house. We are 3 Oxford-trained neuroscientists supported by an experienced SAB from Harvard, Science Corp (ex-N
Y Combinator
yc-company-directory #5839We use AI and high-throughput mouse studies to discover therapeutics that modify neural activity in the brain. The initial focus is on epilepsies associated with autism and Parkinson’s disease with the potential to expand to any neurological disorder underlined by a dysfunction in neural activity. Our R&D is guided by AI models trained on high-density multimodal mouse data generated in-house. We are 3 Oxford-trained neuroscientists supported by an experienced SAB from Harvard, Science Corp (ex-N
sourceExin Therapeutics is classified as AI infrastructure from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.
Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.
Companies similar to Exin Therapeutics
A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.
SynsoryBio
match 56SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.
shared extracted concept terms: therapeutic; shared product terms: therapeutic, disease, potential, expand; shared product theme: health and clinical care; shared affiliation: Y Combinator
Torpedo Therapeutics
match 46We are building high-precision implantable neuromodulation devices that can sense and stimulate neural activity in the brain with the goal of transforming the efficacy and adoption of deep brain stimulation (DBS), an existing FDA-approved therapy used to treat Parkinson’s, essential tremor and epilepsy.
shared product terms: high, neural, activity, brain; shared product theme: context and memory; shared affiliation: Y Combinator
smallTalk
match 40smallTalk has created an innovative speaker system to bring recorded caregiver voices to NICU babies. The NICU Egg enhances parent-baby bonding, while the ACTIVE Egg, paired with a sensor-equipped pacifier, aims to support brain development in preterm infants upon FDA clearance. Blending neurodevelopmental science with the power of voice, we empower NICU families--and soon, we'll expand into homes with products for language and early childhood development.
shared product terms: brain, expand, support, science; shared product theme: context and memory; same category: AI infrastructure
NeuroX1
match 36Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.
shared extracted concepts: therapeutics; shared product terms: therapeutic, disorder; shared product theme: health and clinical care; same category: AI infrastructure
Modulari-T
match 36Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise. Modulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This can be used to engineer immune cells to efficiently recognize and kill cancer cells or to create stem cells able to regenerate any tissue. Modulari-T looks to expand its technology to reach every area of cell therap
shared product terms: any, disease, modify, expand; same category: AI infrastructure; shared affiliation: Y Combinator
Luel
match 28Luel is a sourcing and licensing platform for rights-cleared multimodal training data at scale. We work with frontier AI teams to provide high-quality bespoke data collections and off-the-shelf datasets.
shared product terms: multimodal, train, high; same category: AI infrastructure; shared affiliation: Y Combinator